1211540-74-7

Basic information

• Product Name: (5-BroMo-3-nitropyridin-2-yl)acetic acid ethyl ester
• Synonyms: (5-BroMo-3-nitropyridin-2-yl)acetic acid ethyl ester;ethyl 2-(5-broMo-3-nitropyridin-2-yl)acetate;2-(5-Bromo-3-nitropyridinyl) acetic acid ethyl ester
• CAS NO: 1211540-74-7
• Molecular Formula: C₉H₉BrN₂O₄
• Molecular Weight: 289.08276
• Mol File: 1211540-74-7.mol
• Article Data: 7

Chemical Properties

• Appearance: /
• Storage Temp.: Inert atmosphere,Room Temperature
• CAS DataBase Reference: (5-BroMo-3-nitropyridin-2-yl)acetic acid ethyl ester(CAS DataBase Reference)
• NIST Chemistry Reference: (5-BroMo-3-nitropyridin-2-yl)acetic acid ethyl ester(1211540-74-7)
• EPA Substance Registry System: (5-BroMo-3-nitropyridin-2-yl)acetic acid ethyl ester(1211540-74-7)

Safety Data

• Hazardous Substances Data: 1211540-74-7(Hazardous Substances Data)

Usage

General Description

(5-Bromo-3-nitropyridin-2-yl)acetic acid ethyl ester is a chemical compound with the molecular formula C9H9BrN2O4. It is an ethyl ester derivative of (5-bromo-3-nitropyridin-2-yl)acetic acid, and is commonly used in organic synthesis and medicinal chemistry. This chemical is known for its potential pharmacological activities, and it has been studied for its potential use in the development of new drugs. It is also used as a reagent in chemical reactions, particularly in the formation of carbon-carbon bonds. (5-BroMo-3-nitropyridin-2-yl)acetic acid ethyl ester is a yellow solid at room temperature, and is sparingly soluble in water but more soluble in organic solvents such as ethanol and acetone. It is important in the field of medicinal chemistry and drug discovery.

Upstream product

• 67443-38-3 5-bromo-2-chloro-3-nitropyridine 
• 6148-64-7 ethyl potassium malonate 
• 911434-04-3 2-(5-bromo-3-nitro-pyridin-2-yl)-malonic acid diethyl ester 

Downstream Products

• 1379312-86-3 ethyl 2-(3-Amino-5-bromopyridin-2-yl)acetate 
• 1190319-62-0 6-bromo-1,3-dihydro-2H-pyrrolo[3,2-b]pyridin-2-one 

Relevant articles and documents

TRIAZINE DERIVATIVE HAVING EGFR INHIBITORY ACTIVITY, PREPARATION METHOD THEREFOR AND USE THEREOF

Disclosed are a triazine derivative having EGFR inhibitory activity, a preparation method therefor and use thereof. In particular, disclosed are an EGFR inhibitor having a structure of formula (I), a preparation method therefor, a pharmaceutical composition containing same, use thereof for preparing the EGFR inhibitor, and use thereof in preparing medicaments for treating and/or preventing cancers, tumors or metastatic diseases at least partially related to insertion, deletion or other mutation of EGFR exon 20, and in particular use thereof in preparing medicaments for treating and/or preventing hyperproliferative diseases and diseases inducing cell death disorders. The definition of each substituent of formula (I) is the same as that in the description.

SPIROCYCLIC INDOLINES AS IL-17 MODULATORS

A series of substituted spirocyclic 2-oxoindoline derivatives, and analogues thereof, being potent modulators of human IL-17 activity, are accordingly of benefit in the treatment and/or prevention of various human ailments, including inflammatory and autoimmune disorders.

HETEROCYCLIC COMPOUND

A compound represented by the formula (I): wherein each symbol is as described in the SPECIFICATION, or a salt thereof has a PDE2A inhibitory action, and is useful as a prophylactic or therapeutic drug for schizophrenia, Alzheimer's disease and the like.